131 related articles for article (PubMed ID: 36646189)
1. Metabolic landscape dysregulation in bronchoalveolar lavage fluid of checkpoint inhibitor pneumonitis.
Yu W; He Y; Shang Y; Guo T; Wang K; Liang H; Xue J; Ma X; Mu X; Li R; Gao Z
Clin Immunol; 2023 Feb; 247():109230. PubMed ID: 36646189
[TBL] [Abstract][Full Text] [Related]
2. Bronchoalveolar lavage fluid and blood natural killer and natural killer T-like cells in cryptogenic organizing pneumonia.
Papakosta D; Manika K; Gounari E; Kyriazis G; Kontakiotis T; Spyropoulos G; Kontakioti E; Zarogoulidis K
Respirology; 2014 Jul; 19(5):748-54. PubMed ID: 24889556
[TBL] [Abstract][Full Text] [Related]
3. Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case-control study.
Si X; Zheng X; Tian X; Wang H; Xu Y; Zhao J; Chen M; Zhong W; Wang M; Zhang L; Zhang X
Thorac Cancer; 2023 Jul; 14(21):2038-2044. PubMed ID: 37259819
[TBL] [Abstract][Full Text] [Related]
4. The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis.
Suresh K; Naidoo J; Zhong Q; Xiong Y; Mammen J; de Flores MV; Cappelli L; Balaji A; Palmer T; Forde PM; Anagnostou V; Ettinger DS; Marrone KA; Kelly RJ; Hann CL; Levy B; Feliciano JL; Lin CT; Feller-Kopman D; Lerner AD; Lee H; Shafiq M; Yarmus L; Lipson EJ; Soloski M; Brahmer JR; Danoff SK; D'Alessio F
J Clin Invest; 2019 Jul; 129(10):4305-4315. PubMed ID: 31310589
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
[TBL] [Abstract][Full Text] [Related]
6. Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis.
Cui P; Li J; Tao H; Li X; Wu L; Ma J; Wang H; Liu T; Zhang M; Hu Y
Oncogene; 2023 Oct; 42(42):3098-3112. PubMed ID: 37653115
[TBL] [Abstract][Full Text] [Related]
7. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of IL-17A and IL-35 in plasma and bronchoalveolar lavage fluid are associated with checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer.
Wang YN; Lou DF; Li DY; Jiang W; Dong JY; Gao W; Chen HC
Oncol Lett; 2020 Jul; 20(1):611-622. PubMed ID: 32565986
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case-control study.
Kowalski B; Valaperti A; Bezel P; Steiner UC; Scholtze D; Wieser S; Vonow-Eisenring M; Widmer A; Kohler M; Franzen D
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1711-1720. PubMed ID: 34347128
[TBL] [Abstract][Full Text] [Related]
10. Bronchoalveolar lavage fluid eosinophils are correlated to natural killer cells in eosinophilic pneumonias.
Papakosta D; Manika K; Kyriazis G; Kontakiotis T; Gioulekas D; Polyzoni T; Bouros D; Patakas D
Respiration; 2009; 78(2):177-84. PubMed ID: 19246876
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis.
Lin X; Deng J; Deng H; Yang Y; Sun N; Zhou M; Qin Y; Xie X; Li S; Zhong N; Song Y; Zhou C
Front Immunol; 2021; 12():818492. PubMed ID: 35095920
[TBL] [Abstract][Full Text] [Related]
12. mRNA expression profile of bronchoalveolar lavage fluid cells from patients with idiopathic pulmonary fibrosis and sarcoidosis.
Paplińska-Goryca M; Goryca K; Misiukiewicz-Stępień P; Nejman-Gryz P; Proboszcz M; Górska K; Maskey-Warzęchowska M; Krenke R
Eur J Clin Invest; 2019 Sep; 49(9):e13153. PubMed ID: 31246273
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
14. Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia.
Katoh S; Ikeda M; Shimizu H; Abe M; Ohue Y; Mouri K; Kobashi Y; Oka M
Lung; 2015 Oct; 193(5):683-9. PubMed ID: 26249221
[TBL] [Abstract][Full Text] [Related]
15. Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma.
Strippoli S; Fucci L; Negri A; Putignano D; Cisternino ML; Napoli G; Filannino R; De Risi I; Sciacovelli AM; Guida M
J Transl Med; 2020 Dec; 18(1):473. PubMed ID: 33302981
[TBL] [Abstract][Full Text] [Related]
16. Can circulating interleukin-18 differentiate between sarcoidosis and idiopathic pulmonary fibrosis?
Liu DH; Cui W; Chen Q; Huang CM
Scand J Clin Lab Invest; 2011 Nov; 71(7):593-7. PubMed ID: 21834618
[TBL] [Abstract][Full Text] [Related]
17. Activated CD8+ T cells and natural killer T cells in bronchoalveolar lavage fluid in hypersensitivity pneumonitis and sarcoidosis.
Tøndell A; Rø AD; Børset M; Moen T; Sue-Chu M
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):316-24. PubMed ID: 25591143
[TBL] [Abstract][Full Text] [Related]
18. IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung disease.
Jehn LB; Costabel U; Boerner E; Wessendorf TE; Theegarten D; Taube C; Bonella F
Immunobiology; 2022 Sep; 227(5):152258. PubMed ID: 35998415
[TBL] [Abstract][Full Text] [Related]
19. Tumor invasion in the central airway is a risk factor for early-onset checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer.
Moda M; Saito H; Kato T; Usui R; Kondo T; Nakahara Y; Murakami S; Yamamoto K; Yamada K
Thorac Cancer; 2020 Dec; 11(12):3576-3584. PubMed ID: 33078531
[TBL] [Abstract][Full Text] [Related]
20. Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts.
Bouros E; Filidou E; Arvanitidis K; Mikroulis D; Steiropoulos P; Bamias G; Bouros D; Kolios G
Pulm Pharmacol Ther; 2017 Oct; 46():78-87. PubMed ID: 28865842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]